Academia Sinica Life Science Library -- Publications

:::

Publications

Inst. of Biomedical Sciences - 李家偉 Li, Chia-Wei

Journal

Huang Hsiang‐Chi, Wang Shih‐Han, Fang Guo‐Chen, Chou Wen‐Cheng, Liao Chun‐Che, Sun Cheng‐Pu, Jan Jia‐Tsrong, Ma Hsiu‐Hua, Ko Hui‐Ying, Ko Yi‐An, Chiang Ming‐Tsai, Liang Jian‐Jong, Kuo Chun‐Tse, Lee Te‐An, Morales‐Scheihing Diego, Shen Chen‐Yang, Chen Shih‐Yu, McCullough Louise D., Cui Lu, Wernig Gerlinde, Tao Mi‐Hua, Lin Yi‐Ling, Chang Yao‐Ming*, Wang Shu‐Ping*, Lai Yun‐Ju*, (Li Chia‐Wei*). Upregulation of PD‐L1 by SARS‐CoV‐2 promotes immune evasion. Journal of Medical Virology. 95(2), 1-17, 2023-01-07. [JCR]　[WOS]
Shih-Han Wang, Wen-Cheng Chou, Hsiang-Chi Huang, Te-An Lee, Tzu-Chun Hsiao, Ling-Hui Wang, Ke-Bin Huang, Chun-Tse Kuo, Chi-Hong Chao, Shing-Jyh Chang, Jung-Mao Hsu, Jialei Weng, Ning Ren, Fu-An Li, Yun-Ju Lai, Chenhao Zhou, Mien-Chie Hung, (Chia-Wei Li*). Deglycosylation of SLAMF7 in breast cancers enhances phagocytosis. AMERICAN JOURNAL OF CANCER RESEARCH. 12(10), 4721-4736, 2022. [JCR]　[WOS]
Lee TA, Wang SH, Kuo CT, (Li CW), McCullough LD, Bello D, Lai YJ. Prognostic serum biomarkers in cancer patients with COVID-19: A systematic review. Translational oncology. 21, 101443, 2022. [JCR]　[WOS]
Hsiang-Chi Huang, Chun-Che Liao, Shih-Han Wang, I-Jung Lee, Te-An Lee, Jung-Mao Hsu, Chun-Tse Kuo, Jyun Wang, Wan-Chen Hsieh, Shing-Jyh Chang, Shih-Yu Chen, Mi-Hua Tao, Yi-Ling Lin, Yun-Ju Lai, (Chia-Wei Li*). Hyperglycosylated spike of SARS-CoV-2 gamma variant induces breast cancer metastasis. AMERICAN JOURNAL OF CANCER RESEARCH. 11(10), 4994-5005, 2021-10-15. [JCR]　[WOS]
Yun-Ju Lai, Chi-Hong Chao, Chun-Che Liao, Te-An Lee, Jung-Mao Hsu, Wen-Cheng Chou, Jyun Wang, Hsiang-Chi Huang, Shing-Jyh Chang, Yi-Ling Lin, and (Chia-Wei Li*). Epithelial-mesenchymal transition induced by SARS-CoV-2 required transcriptional upregulation of Snail. AMERICAN JOURNAL OF CANCER RESEARCH. 11(5), 2278-2290, 2021-05-15. [JCR]　[WOS]
Qiu Yufan, Yang Yi, Yang Riyao, Liu Chunxiao, Hsu Jung-Mao, Jiang Zhou, Sun Linlin, Wei Yongkun, (Li Chia-Wei), Yu Dihua, Zhang Jin, Hung Mien-Chie. Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer. Oncogene. 40(31), 4992-5001, 2021. [JCR]　[WOS]
Chao Chi-Hong, Wang Chen-Yun, Wang Cing-Hong, Chen Ting-Wen, Hsu Huai-Yu, Huang Hao-Wei, (Li Chia-Wei), Mai Ru-Tsun. Mutant p53 Attenuates Oxidative Phosphorylation and Facilitates Cancer Stemness through Downregulating miR-200c–PCK2 Axis in Basal-Like Breast Cancer. Molecular Cancer Research. 19(11), 1900-1916, 2021. [JCR]　[WOS]
Hsieh Wan-Chen, Lai En-Yu, Liu Yu-Ting, Wang Yi-Fu, Tzeng Yi-Shiuan, Cui Lu, Lai Yun-Ju, Huang Hsiang-Chi, Huang Jia-Hsin, Ni Hung-Chih, Tsai Dong-Yan, Liang Jian-Jong, Liao Chun-Che, Lu Ya-Ting, Jiang Laurence, Liu Ming-Tsan, Wang Jann-Tay, Chang Sui-Yuan, Chen Chung-Yu, Tsai Hsing-Chen, Chang Yao-Ming, Wernig Gerlinde, (Li Chia-Wei), Lin Kuo-I, Lin Yi-Ling, Tsai Huai-Kuang, Huang Yen-Tsung, Chen Shih-Yu. NK cell receptor and ligand composition influences the clearance of SARS-CoV-2. Journal of Clinical Investigation. 131(21), e146408, 2021. [JCR]　[WOS]
Yin Xin-Ke, Wang Yun-Long, Wang Fei, Feng Wei-Xing, Bai Shao-Mei, Zhao Wan-Wen, Feng Li-Li, Wei Ming-Biao, Qin Cao-Litao, Wang Fang, Chen Zhi-Li, Yi Hong-Jun, Huang Yan, Xie Pei-Yi, Kim Taewan, Wang Ying-Nai, Hou Jun-Wei, (Li Chia-Wei), Liu Quentin, Fan Xin-Juan, Hung Mien-Chie, Wan Xiang-Bo. PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer. Oncogene. 40(7), 1375-1389, 2021. [JCR]　[WOS]
Sun Cheng-Pu, Jan Jia-Tsrong, Wang I-Hsuan, Ma Hsiu-Hua, Ko Hui-Ying, Wu Ping-Yi, Kuo Tzu-Jiun, Liao Hsin-Ni, Lan Yu-Hua, Sie Zong-Lin, Chen Yen-Hui, Ko Yi-An, Liao Chun-Che, Chen Liang-Yu, Lee I-Jung, Tsung Szu-I, Lai Yun-Ju, Chiang Ming-Tsai, Liang Jian-Jong, Liu Wen-Chun, Wang Jing-Rong, Yuan Joyce Pei-Yi, Lin Yin-Shiou, Tsai Yi-Ching, Hsieh Shie-Liang, (Li Chia-Wei), Wu Han-Chung, Ko Tai-Ming, Lin Yi-Ling, Tao Mi-Hua. Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19. PLOS Pathogens. 17(8), e1009758, 2021. [JCR]　[WOS]
Huang Hsiang-Chi, Lai Yun-Ju, Liao Chun-Che, Yang Wang-Feng, Huang Ke-Bin, Lee I-Jung, Chou Wen-Cheng, Wang Shih-Han, Wang Ling-Hui, Hsu Jung-Mao, Sun Cheng-Pu, Kuo Chun-Tse, Wang Jyun, Hsiao Tzu-Chun, Yang Po-Jiun, Lee Te-An, Huang Wilson, Li Fu-An, Shen Chen-Yang, Lin Yi-Ling, Tao Mi-Hua, (Li Chia-Wei*). Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro. EBioMedicine. 74, 103712, 2021. [JCR]　[WOS]
Linlin Sun#, (Chia-Wei Li#), Ezra M Chung#, Riyao Yang#, Yong-Soo Kim, Andrew H Park, Yun-Ju Lai, Yi Yang, Yu-Han Wang, Jielin Liu, Yufan Qiu, Kay-Hooi Khoo, Jun Yao, Jennifer L Hsu, Jong-Ho Cha, Li-Chuan Chan, Jung-Mao Hsu, Heng-Huan Lee, Stephen S Yoo, Mien-Chie Hung*. Targeting Glycosylated PD-1 Induces Potent Antitumor Immunity. CANCER RESEARCH. 80(11), 2298-2310, 2020-06-01. [JCR]　[WOS]
Liu Chunxiao, Zha Zhengyu, Zhou Chenhao, Chen Yeh, Xia Weiya, Wang Ying-Nai, Lee Heng-Huan, Yin Yirui, Yan Meisi, Chang Chiung-Wen, Chan Li-Chuan, Qiu Yufan, Li Hui, (Li Chia-Wei), Hsu Jung-Mao, Hsu Jennifer L., Wang Shao-Chun, Ren Ning, Hung Mien-Chie. Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma. Journal of Hepatology. 74(4), 907-918, 2020. [JCR]　[WOS]
Zhu Y, Yang J, Xu D, Gao XM, Zhang Z, Hsu JL, (Li CW), Lim SO, Sheng YY, Zhang Y, Li JH, Luo Q, Zheng Y, Zhao Y, Lu L, Jia HL, Hung MC, Dong QZ, Qin LX*. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade. Gut. 68(9), 1653-1666, 2019-09. [JCR]　[WOS]
Chan Li-Chuan, (Li Chia-Wei), Xia Weiya, Hsu Jung-Mao, Lee Heng-Huan, Cha Jong-Ho, Wang Hung-Ling, Yang Wen-Hao, Yen Er-Yen, Chang Wei-Chao, Zha Zhengyu, Lim Seung-Oe, Lai Yun-Ju, Liu Chunxiao, Liu Jielin, Dong Qiongzhu, Yang Yi, Sun Linlin, Wei Yongkun, Nie Lei, Hsu Jennifer L., Li Hui, Ye Qinghai, Hassan Manal M., Amin Hesham M., Kaseb Ahmed O., Lin Xin, Wang Shao-Chun, Hung Mien-Chie*. IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion. Journal of Clinical Investigation. 129(8) 3324-3338, 2019-08. [JCR]　[WOS]
Li H#, (Li CW#), Li X, Ding Q, Guo L, Liu S, Liu C, Lai CC, Hsu JM, Dong Q, Xia W, Hsu JL, Yamaguchi H, Du Y, Lai YJ, Sun X, Koller PB, Ye Q, Hung MC*, # Contributed equally. MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. Gastroenterology. 156(6), 1849-1861.e13, 2019-05. [JCR]　[WOS]
Yang Y, Hsu JM, Sun L, Chan LC, (Li CW), Hsu JL, Wei Y, Xia W, Hou J, Qiu Y, Hung MC*. Palmitoylation stabilizes PD-L1 to promote breast tumor growth. Cell research. 29(1), 83-86, 2019-01. [JCR]　[WOS]
Han Y, (Li CW*), Hsu JM, Hsu JL, Chan LC, Tan X, He GJ. Metformin reverses PARP inhibitors-induced epithelial-mesenchymal transition and PD-L1 upregulation in triple-negative breast cancer. American journal of cancer research. 9(4), 800-815, 2019. [JCR]　[WOS]
Han Y, Chen MK, Wang HL, Hsu JL, (Li CW), Chu YY, Liu CX, Nie L, Chan LC, Yam C, Wang SC, He GJ, Hortobagyi GN, Tan XD, Hung MC*. Synergism of PARP inhibitor fluzoparib (HS10160) and MET inhibitor HS10241 in breast and ovarian cancer cells. American journal of cancer research. 9(3), 608-618, 2019. [JCR]　[WOS]
(Li CW), Lai YJ, Hsu JL, Hung MC*. Activation of phagocytosis by immune checkpoint blockade. Frontiers of medicine. 12(4), 473-480, 2018. [JCR]　[WOS]
Ding Q, Wang Y, Zuo Z, Gong Y, Krishnamurthy S, (Li CW), Lai YJ, Wei W, Wang J, Manyam GC, Diao L, Zhang X, Lin F, Symmans WF, Sun L, Liu CG, Liu X, Debeb BG, Ueno NT, Harano K, Alvarez RH, Wu Y, Cristofanilli M, Huo L*. Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancer. Human pathology. 77, 121-129, 2018. [JCR]　[WOS]
Shao B, (Li CW), Lim SO, Sun L, Lai YJ, Hou J, Liu C, Chang CW, Qiu Y, Hsu JM, Chan LC, Zha Z, Li H, Hung MC*. Deglycosylation of PD-L1 by 2-deoxyglucose reverses PARP inhibitor-induced immunosuppression in triple-negative breast cancer. American journal of cancer research. 8(9), 1837-1846, 2018. [JCR]　[WOS]
(Li CW#), Lim SO#, Chung EM, Kim YS, Park AH, Yao J, Cha JH, Xia W, Chan LC, Kim T, Chang SS, Lee HH, Chou CK, Liu YL, Yeh HC, Perillo EP, Dunn AK, Kuo CW, Khoo KH, Hsu JL, Wu Y, Hsu JM, Yamaguchi H, Huang TH, Sahin AA, Hortobagyi GN, Yoo SS, Hung MC*, # contributed equally. Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1. Cancer cell. 33(2), 187-201.e10, 2018. [JCR]　[WOS]
Yang Y, (Li CW), Chan LC, Wei Y, Hsu JM, Xia W, Cha JH, Hou J, Hsu JL, Sun L, Hung MC*. Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth. Cell research. 28(8), 862-864, 2018. [JCR]　[WOS]
Sun LL, Yang RY, (Li CW), Chen MK, Shao B, Hsu JM, Chan LC, Yang Y, Hsu JL, Lai YJ, Hung MC*. Inhibition of ATR downregulates PD-L1 and sensitizes tumor cells to T cell-mediated killing. American journal of cancer research. 8(7), 1307-1316, 2018. [JCR]　[WOS]
Cha JH, Yang WH, Xia W, Wei Y, Chan LC, Lim SO, (Li CW), Kim T, Chang SS, Lee HH, Hsu JL, Wang HL, Kuo CW, Chang WC, Hadad S, Purdie CA, McCoy AM, Cai S, Tu Y, Litton JK, Mittendorf EA, Moulder SL, Symmans WF, Thompson AM, Piwnica-Worms H, Chen CH, Khoo KH, Hung MC*. Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1. Molecular cell. 71(4), 606-620.e7, 2018. [JCR]　[WOS]
Hsu JM#, (Li CW#), Lai YJ, Hung MC*, # Contributed equally. Posttranslational Modifications of PD-L1 and Their Applications in Cancer Therapy. Cancer research. 78(22), 6349-6353, 2018. [JCR]　[WOS]
Hsu JM, Xia W, Hsu YH, Chan LC, Yu WH, Cha JH, Chen CT, Liao HW, Kuo CW, Khoo KH, Hsu JL, (Li CW), Lim SO, Chang SS, Chen YC, Ren GX, Hung MC*. STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion. Nature communications. 9(1), 1908, 2018. [JCR]　[WOS]
Jiao S, Xia W, Yamaguchi H, Wei Y, Chen MK, Hsu JM, Hsu JL, Yu WH, Du Y, Lee HH, (Li CW), Chou CK, Lim SO, Chang SS, Litton J, Arun B, Hortobagyi GN, Hung MC*. PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression. Clinical cancer research : an official journal of the American Association for Cancer Research. 23(14), 3711-3720, 2017. [JCR]　[WOS]
(Li CW#), Lim SO#, Hsu JL, Hung MC*, # contributed equally. Rational combination of immunotherapy for triple negative breast cancer treatment. Chinese clinical oncology. 6(5), 54, 2017. [JCR]　[WOS]
(Li CW), Xia W, Lim SO, Hsu JL, Huo L, Wu Y, Li LY, Lai CC, Chang SS, Hsu YH, Sun HL, Kim J, Yamaguchi H, Lee DF, Wang H, Wang Y, Chou CK, Hsu JM, Lai YJ, LaBaff AM, Ding Q, Ko HW, Tsai FJ, Tsai CH, Hortobagyi GN, Hung MC*. AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation. Cancer research. 76(6), 1451-62, 2016. [JCR]　[WOS]
Lim SO#, (Li CW#), Xia W, Cha JH, Chan LC, Wu Y, Chang SS, Lin WC, Hsu JM, Hsu YH, Kim T, Chang WC, Hsu JL, Yamaguchi H, Ding Q, Wang Y, Yang Y, Chen CH, Sahin AA, Yu D, Hortobagyi GN, Hung MC*, # contributed equally. Deubiquitination and Stabilization of PD-L1 by CSN5. Cancer cell. 30(6), 925-939, 2016. [JCR]　[WOS]
Lim SO, (Li CW), Xia W, Lee HH, Chang SS, Shen J, Hsu JL, Raftery D, Djukovic D, Gu H, Chang WC, Wang HL, Chen ML, Huo L, Chen CH, Wu Y, Sahin A, Hanash SM, Hortobagyi GN, Hung MC*. EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape. Cancer research. 76(5), 1284-96, 2016. [JCR]　[WOS]
(Li CW#), Lim SO#, Xia W, Lee HH, Chan LC, Kuo CW, Khoo KH, Chang SS, Cha JH, Kim T, Hsu JL, Wu Y, Hsu JM, Yamaguchi H, Ding Q, Wang Y, Yao J, Lee CC, Wu HJ, Sahin AA, Allison JP, Yu D, Hortobagyi GN, Hung MC*, # contributed equally. Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity. Nature communications. 7, 12632, 2016. [JCR]　[WOS]
Ko HW, Lee HH, Huo L, Xia W, Yang CC, Hsu JL, Li LY, Lai CC, Chan LC, Cheng CC, Labaff AM, Liao HW, Lim SO, (Li CW), Wei Y, Nie L, Yamaguchi H, Hung MC*. GSK3beta inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers. Oncotarget. 7(35), 57131-57144, 2016. [JCR]　[WOS]
Wang Y, Hsu JM, Kang Y, Wei Y, Lee PC, Chang SJ, Hsu YH, Hsu JL, Wang HL, Chang WC, (Li CW), Liao HW, Chang SS, Xia W, Ko HW, Chou CK, Fleming JB, Wang H, Hwang RF, Chen Y, Qin J, Hung MC*. Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated Methylation. Cancer research. 76(23), 7049-7058, 2016. [JCR]　[WOS]
Wu TJ, Chang SS, (Li CW), Hsu YH, Chen TC, Lee WC, Yeh CT, Hung MC*. Severe Hepatitis Promotes Hepatocellular Carcinoma Recurrence via NF-kappaB Pathway-Mediated Epithelial-Mesenchymal Transition after Resection. Clinical cancer research : an official journal of the American Association for Cancer Research. 22(7), 1800-12, 2016. [JCR]　[WOS]
Rahal OM, Nie L, Chan LC, (Li CW), Hsu YH, Hsu J, Yu D, Hung MC*. Selective expression of constitutively active pro-apoptotic protein BikDD gene in primary mammary tumors inhibits tumor growth and reduces tumor initiating cells. American journal of cancer research. 5(12), 3624-34, 2015. [JCR]　[WOS]
Huo L, (Li CW), Huang TH, Lam YC, Xia W, Tu C, Chang WC, Hsu JL, Lee DF, Nie L, Yamaguchi H, Wang Y, Lang J, Li LY, Chen CH, Mishra L, Hung MC*. Activation of Keap1/Nrf2 signaling pathway by nuclear epidermal growth factor receptor in cancer cells. American journal of translational research. 6(6), 649-63, 2014. [JCR]　[WOS]
Hsu YH, Yao J, Chan LC, Wu TJ, Hsu JL, Fang YF, Wei Y, Wu Y, Huang WC, Liu CL, Chang YC, Wang MY, (Li CW), Shen J, Chen MK, Sahin AA, Sood A, Mills GB, Yu D, Hortobagyi GN, Hung MC*. Definition of PKC-alpha, CDK6, and MET as therapeutic targets in triple-negative breast cancer. Cancer research. 74(17), 4822-35, 2014. [JCR]　[WOS]
Thirumurthi U, Shen J, Xia W, LaBaff AM, Wei Y, (Li CW), Chang WC, Chen CH, Lin HK, Yu D, Hung MC*. MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer. Science signaling. 7(336), ra71, 2014. [JCR]　[WOS]
(Li CW), Xia W, Huo L, Lim SO, Wu Y, Hsu JL, Chao CH, Yamaguchi H, Yang NK, Ding Q, Wang Y, Lai YJ, LaBaff AM, Wu TJ, Lin BR, Yang MH, Hortobagyi GN, Hung MC*. Epithelial-mesenchymal transition induced by TNF-alpha requires NF-kappaB-mediated transcriptional upregulation of Twist1. Cancer research. 72(5), 1290-300, 2012. [JCR]　[WOS]
Wang Y, Ding Q, Yen CJ, Xia W, Izzo JG, Lang JY, (Li CW), Hsu JL, Miller SA, Wang X, Lee DF, Hsu JM, Huo L, Labaff AM, Liu D, Huang TH, Lai CC, Tsai FJ, Chang WC, Chen CH, Wu TT, Buttar NS, Wang KK, Wu Y, Wang H, Ajani J, Hung MC*. The crosstalk of mTOR/S6K1 and Hedgehog pathways. Cancer cell. 21(3), 374-87, 2012. [JCR]　[WOS]
Song H, (Li CW), Labaff AM, Lim SO, Li LY, Kan SF, Chen Y, Zhang K, Lang J, Xie X, Wang Y, Huo LF, Hsu SC, Chen X, Zhao Y, Hung MC*. Acetylation of EGF receptor contributes to tumor cell resistance to histone deacetylase inhibitors. Biochemical and biophysical research communications. 404(1), 68-73, 2011. [JCR]　[WOS]
Ding Q, Chang CJ, Xie X, Xia W, Yang JY, Wang SC, Wang Y, Xia J, Chen L, Cai C, Li H, Yen CJ, Kuo HP, Lee DF, Lang J, Huo L, Cheng X, Chen YJ, (Li CW), Jeng LB, Hsu JL, Li LY, Tan A, Curley SA, Ellis LM, Dubois RN, Hung MC*. APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis. The Journal of clinical investigation. 121(11), 4526-36, 2011. [JCR]　[WOS]
Chang CJ, Chao CH, Xia W, Yang JY, Xiong Y, (Li CW), Yu WH, Rehman SK, Hsu JL, Lee HH, Liu M, Chen CT, Yu D, Hung MC*. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nature cell biology. 13(3), 317-U296, 2011. [JCR]　[WOS]
(Li CW), Ai N, Dinh GK, Welsh WJ, Chen JD*. Human ADA3 regulates RARalpha transcriptional activity through direct contact between LxxLL motifs and the receptor coactivator pocket. Nucleic acids research. 38(16), 5291-5303, 2010. [JCR]　[WOS]
(Li CW), Dinh GK, Chen JD*. Preferential physical and functional interaction of pregnane X receptor with the SMRTalpha isoform. Molecular pharmacology. 75(2), 363-373, 2009. [JCR]　[WOS]
(Li CW), Dinh GK, Zhang A, Chen JD*. Ankyrin repeats-containing cofactors interact with ADA3 and modulate its co-activator function. The Biochemical journal. 413(2), 349-357, 2008. [JCR]　[WOS]
Zhang A, (Li CW), Chen JD*. Characterization of transcriptional regulatory domains of ankyrin repeat cofactor-1. Biochemical and biophysical research communications. 358(4), 1034-1040, 2007. [JCR]　[WOS]
Zhang A, (Li CW), Tsai SC, Chen JD*. Subcellular localization of ankyrin repeats cofactor-1 regulates its corepressor activity. Journal of cellular biochemistry. 101(5), 1301-1315, 2007. [JCR]　[WOS]
Johnson DR#, (Li CW#), Chen LY, Ghosh JC, Chen JD*, # contributed equally. Regulation and binding of pregnane X receptor by nuclear receptor corepressor silencing mediator of retinoid and thyroid hormone receptors (SMRT). Molecular pharmacology. 69(1), 99-108, 2006. [JCR]　[WOS]
Zhang A, Yeung PL, (Li CW), Tsai SC, Dinh GK, Wu X, Li H, Chen JD*. Identification of a novel family of ankyrin repeats containing cofactors for p160 nuclear receptor coactivators. The Journal of biological chemistry. 279(32), 33799-33805, 2004. [JCR]　[WOS]

Book